Loading...

Pacific Blue™ anti-mouse I-A/I-E Antibody

Pricing & Availability
Clone
M5/114.15.2 (See other available formats)
Regulatory Status
RUO
Other Names
MHC class II
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M5_114_15_2_Blue_091207
C57BL/6 mouse splenocytes were stained with anti-mouse I-A/I-E (clone M5/114.15.2) Pacific Blue™ (filled histogram) or rat IgG2b, κ Pacific Blue™ isotype control (open histogram).
  • M5_114_15_2_Blue_091207
    C57BL/6 mouse splenocytes were stained with anti-mouse I-A/I-E (clone M5/114.15.2) Pacific Blue™ (filled histogram) or rat IgG2b, κ Pacific Blue™ isotype control (open histogram).
Compare all formats See Pacific Blue™ spectral data
Cat # Size Price Quantity Check Availability Save
107619 25 µg 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
107620 100 µg 172€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

These class II molecules are expressed on antigen presenting cells (including B cells) and a subset of T cells from H-2b,d,q,r bearing mice and are involved in antigen presentation to T cells expressing CD3/TCR and CD4 proteins.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Activated C57BL/6 mouse spleen cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with Pacific Blue™ under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The I-A/I-E antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Pacific Blue™ has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue™ conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Violet Laser (405 nm)
Application Notes

The M5/114.15.2 antibody reacts with a polymorphic determinant shared by the I-Ab, I-Ad, I-Aq, I-Ed, and I-Ek MHC class II alloantigens from mice carrying H-2p,r,q,b,d,u haplotypes. Clone M5/114.15.2 however does not react wtih I-Af, I-Ak, or I-As MHC class II alloantigens.1

Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemistry of frozen sections2,3,6, in vitro and in vivo blocking of antigen presentation or ligand binding4-7, and spatial biology (IBEX)17,18. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 107655 & 107656).

Application References
  1. Bhattacharya A, et al. 1981. J. Immunol. 127:2488. (IP)
  2. Viville S, et al. 1993. Cell 72:635. (IHC)
  3. Nelson AJ, et al. 1993. J. Immunol. 151:2453. (IHC)
  4. Shi Y, et al. 1998. J. Exp. Med. 187:367. (Block)
  5. Yamashita I, et al. 1993. Int. Immunol. 5:1139.
  6. Guo M, et al. 1995. Zygote 3:65. (IHC)
  7. Kim A, et al. 2004. Exp. Mol. Med. 36:428. (Block)
  8. Luckashenak NA, et al. 2006. J. Immunol. 177:5177.
  9. Venanzi ES, et al. 2007. J. Immunol. 179:5693.
  10. Christensen SR, et al. 2006. Immunity 25:417. PubMed
  11. Matte-Martone C, et al. 2008. Blood 111:3884. PubMed
  12. De Pascalis R, et al. 2008. Infect. Immun. 76:4311. PubMed
  13. Kuns RD, et al. 2009. Blood 113:5999. PubMed
  14. Sabatino JJ, et al. 2011. J. Exp. Med. 208:81. PubMed
  15. Draber P, et al. 2011. Mol Cell Biol. 22:4550. PubMed
  16. Fu H, et al. 2014. Nat Commun. 5:3436. PubMed
  17. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  18. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  2. Ochiai S, et al. 2014. J Immunol. 193:2504. PubMed
  3. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  4. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  5. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  6. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  7. Hill AA, et al. 2023. JCI Insight. 8: . PubMed
  8. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  9. Slusarczyk P, et al. 2023. Elife. 12: . PubMed
  10. Ives A, et al. 2021. FASEB J. 35:e21418. PubMed
  11. Dhalech AH, et al. 2022. J Virol. 96:e0123222. PubMed
  12. Chang CY, et al. 2022. Sci Adv. 8:eabq0615. PubMed
  13. van Elsas MJ, et al. 2023. J Immunother Cancer. 11:. PubMed
  14. Cansever D, et al. 2023. Nat Immunol. . PubMed
  15. Israelow B, et al. 2020. bioRxiv. . PubMed
  16. Slocombe T, et al. 2013. J Immunol. 191:3128. PubMed
  17. Zahner S, et al. 2011. J Immunol. 187:5069. PubMed
  18. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  19. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  20. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  21. Venanzi E, et al. 2007. J Immunol. 179:5693. PubMed
  22. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  23. Semmrich M, et al. 2011. Mucosal Immunol. 0.3125. PubMed
  24. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  25. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  26. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  27. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  28. Dupont C, et al. 2015. J Immunol. 195: 4369 - 4377. PubMed
  29. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  30. Ayasoufi K, et al. 2020. Brain. 3629:143. PubMed
  31. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  32. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  33. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  34. Kinsella S, et al. 2021. Cell Rep. 37:109789. PubMed
  35. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  36. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  37. Tuganbaev T, et al. 2020. Cell. 182(6):1441-1459.e21. PubMed
  38. Nakajima A, et al. 2014. PLoS One. 9:105904. PubMed
  39. Bunting M, et al. 2013. Blood. 121:118. PubMed
  40. Holly Bachus et al. 2018. Immunity. 50(1):225-240 . PubMed
  41. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  42. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  43. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  44. Yang M, et al. 2021. Cancer Immunol Immunother. 70:2467. PubMed
  45. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  46. Fontinha D, et al. 2015. PLoS One. 10: 0142540. PubMed
  47. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  48. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  49. Steiger S, et al. 2015. J Immunol. 195: 5495 - 5502. PubMed
  50. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  51. Jaensson E, et al. 2008. J Exp Med. 205:2139. PubMed
  52. Huang S, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.75. PubMed
  53. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  54. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  55. Chen Z, et al. 2016. Nat Commun. 7:11596. PubMed
  56. Kim M, et al. 2018. Immunity. 49:151. PubMed
  57. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  58. Hu M, et al. 2019. Nat Commun. 10:3031. PubMed
  59. Schulz O, et al. 2009. J Exp Med. 206:3101. PubMed
  60. Eun S, et al. 2015. J Immunol. 194:134. PubMed
  61. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  62. Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed
  63. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  64. Gerdes P, et al. 2022. Nat Commun. 13:7470. PubMed
  65. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  66. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  67. McCarthy N, et al. 2015. J Immunol. 195: 2675-2682. PubMed
  68. Zhang H et al. 2018. Cell. 175(5):1244-1258 . PubMed
  69. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  70. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  71. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  72. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  73. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  74. Korin B, et al. 2020. Sleep. :43. PubMed
  75. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  76. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  77. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  78. Platteel ACM, et al. 2018. Front Immunol. 1.544444444. PubMed
  79. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  80. White JP et al. 2018. Cell. 175(5):1198-1212 . PubMed
  81. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  82. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  83. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  84. Doo DW, et al. 2020. Ther Adv Med Oncol. 12:1758835920913798. PubMed
  85. Schuijs M, et al. 2016. PLoS One. 11: 016188. PubMed
  86. Ang QY, et al. 2020. Cell. 181(6):1263-1275.e16. PubMed
  87. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  88. Lau A, et al. 2022. Sci Adv. 8:eabm0142. PubMed
  89. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  90. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  91. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  92. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
RRID
AB_493527 (BioLegend Cat. No. 107619)
AB_493527 (BioLegend Cat. No. 107620)

Antigen Details

Structure
MHC class II
Distribution

B cell and activated T cells, APCs of the H-2b,d,q,r bearing mice

Function
Antigen presentation
Ligand/Receptor
CD3/TCR, CD4
Cell Type
Antigen-presenting cells, B cells, Dendritic cells, T cells, Tregs
Biology Area
Immunology, Innate Immunity
Molecular Family
MHC Antigens
Antigen References

1. Watts C. 1997. Ann. Rev. Immunol. 15:821.
2. Pamer E, et al. 1998. Ann. Rev. Immunol. 16:323.

Gene ID
14961 View all products for this Gene ID 14969 View all products for this Gene ID
UniProt
View information about I-A/I-E on UniProt.org

Other Formats

View All I-A/I-E Reagents Request Custom Conjugation
Description Clone Applications
Biotin anti-mouse I-A/I-E M5/114.15.2 FC
FITC anti-mouse I-A/I-E M5/114.15.2 FC
PE anti-mouse I-A/I-E M5/114.15.2 FC
Purified anti-mouse I-A/I-E M5/114.15.2 FC,IHC-F,IP,Block
PE/Cyanine5 anti-mouse I-A/I-E M5/114.15.2 FC
APC anti-mouse I-A/I-E M5/114.15.2 FC
Alexa Fluor® 488 anti-mouse I-A/I-E M5/114.15.2 FC,3D IHC
Alexa Fluor® 647 anti-mouse I-A/I-E M5/114.15.2 FC
Pacific Blue™ anti-mouse I-A/I-E M5/114.15.2 FC
Alexa Fluor® 700 anti-mouse I-A/I-E M5/114.15.2 FC,SB
PerCP/Cyanine5.5 anti-mouse I-A/I-E M5/114.15.2 FC
PerCP anti-mouse I-A/I-E M5/114.15.2 FC
APC/Cyanine7 anti-mouse I-A/I-E M5/114.15.2 FC
PE/Cyanine7 anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 421™ anti-mouse I-A/I-E M5/114.15.2 FC,IHC-F,SB
Brilliant Violet 510™ anti-mouse I-A/I-E M5/114.15.2 FC
Purified anti-mouse I-A/I-E (Maxpar® Ready) M5/114.15.2 FC,CyTOF®
Brilliant Violet 605™ anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 650™ anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 711™ anti-mouse I-A/I-E M5/114.15.2 FC
Brilliant Violet 785™ anti-mouse I-A/I-E M5/114.15.2 FC
PE/Dazzle™ 594 anti-mouse I-A/I-E M5/114.15.2 FC
Alexa Fluor® 594 anti-mouse I-A/I-E M5/114.15.2 IHC-F,3D IHC
APC/Fire™ 750 anti-mouse I-A/I-E M5/114.15.2 FC
TotalSeq™-A0117 anti-mouse I-A/I-E M5/114.15.2 PG
Ultra-LEAF™ Purified anti-mouse I-A/I-E M5/114.15.2 FC,IHC-F,IP,Block
TotalSeq™-B0117 anti-mouse I-A/I-E M5/114.15.2 PG
TotalSeq™-C0117 anti-mouse I-A/I-E M5/114.15.2 PG
Spark Blue™ 550 anti-mouse I-A/I-E M5/114.15.2 FC
PE/Fire™ 640 anti-mouse I-A/I-E M5/114.15.2 FC
Spark YG™ 581 anti-mouse I-A/I-E M5/114.15.2 FC
PE/Fire™ 810 anti-mouse I-A/I-E M5/114.15.2 FC
Spark UV™ 387 anti-mouse I-A/I-E M5/114.15.2 FC
Spark Violet™ 538 anti-mouse I-A/I-E M5/114.15.2 FC
PerCP/Fire™ 806 anti-mouse I-A/I-E M5/114.15.2 FC
Spark Red™ 718 anti-mouse I-A/I-E M5/114.15.2 FC
APC/Fire™ 810 anti-mouse I-A/I-E M5/114.15.2 FC
Spark PLUS UV395™ anti-mouse I-A/I-E M5/114.15.2 FC
Go To Top Version: 4    Revision Date: 10-30-2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account